Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Journey Medical (DERM) Long-Term Debt Issuances (2022 - 2024)

Journey Medical (DERM) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $5.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Long-Term Debt Issuances changed N/A year-over-year to $5.0 million, compared with a TTM value of $10.0 million through Dec 2024, changed N/A, and an annual FY2024 reading of $10.0 million, down 33.33% over the prior year.
  • Long-Term Debt Issuances was $5.0 million for Q4 2024 at Journey Medical, up from -$50000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $14.8 million in Q1 2022 and bottomed at -$50000.0 in Q3 2024.